Treatment of narcolepsy

References

• Westphal C. Eigentümliche mit Einschlafen verbundene Anfälle. Arch. Psychiatr. Nervenkr.7, 631–635 (1877).
   Google Scholar
• Gelineau J. De la narcolepsie. Gaz. Hôp Paris 55, 635–637 (1880).
   Google Scholar
• Nishino S. Clinical and neurobiological aspects of narcolepsy. Sleep Med.8, 373–399 (2007).
   PubMed Web of Science ®Google Scholar
• Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet369, 499–511 (2007).
   PubMed Web of Science ®Google Scholar
• Honda Y. Census of narcolepsy, cataplexy and sleep life among teenagers in Fujisawa city. Sleep Res.8, 191 (1979).
   Google Scholar
• Lavie P, Peled R. Narcolepsy is a rare disease in Israel. Sleep10, 608–609 (1987).
   PubMed Web of Science ®Google Scholar
• Thorpy M. Therapeutic advances in narcolepsy. Sleep Med.8, 427–440 (2007).
   PubMed Web of Science ®Google Scholar
• Ohayon MM, Priest RG, Zulley J, Smirne S, Paiva T. Prevalence of narcolepsy symptomatology and diagnosis in the European general population. Neurology58, 1826–1833 (2002).
   PubMed Web of Science ®Google Scholar
• Silber MH, Krahn LE, Olson EJ, Pankratz VS. The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study. Sleep25, 197–202 (2002).
   PubMed Web of Science ®Google Scholar
• Morrish E, King MA, Smith IE, Shneerson JM. Factors associated with a delay in the diagnosis of narcolepsy. Sleep Med.5(1), 37–41 (2004).
   PubMed Web of Science ®Google Scholar
• Dauvilliers Y, Montplaisir J, Molinari N et al. Age at onset of narcolepsy in two large populations of patients in France and Quebec. Neurology57, 2029–2033 (2001).
   PubMed Web of Science ®Google Scholar
• Orellana C, Villemin E, Tafti M, Carlander B, Besset A, Billiard M. Life events in the year preceding the onset of narcolepsy. Sleep17(Suppl. 8), S50–S53 (1994).
   Google Scholar
• Guilleminault C, Mignot E, Grumet FC. Familial patterns of narcolepsy. Lancet2(8676), 1376–1379 (1989).
   PubMedGoogle Scholar
• Billiard M, Pasquie-Magnetto V, Heckman M, Carlander B, Besset A, Billiard M. Family studies in narcolepsy. Sleep17(Suppl. 8), S54–S59 (1994).
   PubMed Web of Science ®Google Scholar
• American Academy of Sleep Medicine. T he International Classification of Sleep Disorders: Diagnostic and Coding Manual (2nd Edition). American Academy of Sleep Medicine, Chicago, IL, USA (2005).
   Google Scholar
• Scammell TE. The neurobiology, diagnosis, and treatment of narcolepsy. Ann. Neurol.53, 154–166 (2003).
   PubMed Web of Science ®Google Scholar
• Nobili L, Ferrillo F, Besset A, Rosadini G, Schiavi G, Billiard M. Ultradian aspects of sleep in narcolepsy. Neurophysiol. Clin.26, 51–59 (1996).
   PubMedGoogle Scholar
• Roehrs T, Zorick F, Wittig R, Paxton C, Sicklesteel J, Roth T. Alerting effects of naps in patients with narcolepsy. Sleep9, 194–199 (1986).
   PubMed Web of Science ®Google Scholar
• Broughton R, Dunham W, Newman J, Lutley K, Dushesne P, Rivers M. Ambulatory 24 h sleep-wake monitoring in narcolepsy–cataplexy compared to matched control. Electroencephalogr. Clin. Neurophysiol.70, 473–481 (1988).
   PubMedGoogle Scholar
• Nobili L, Besset A, Ferrillo F, Rosadini G, Schiavi G, Billiard M. Dynamics of slow wave activity in narcoleptic patients under bed rest conditions. Electroencephalogr. Clin. Neurophysiol.95(6), 414–425 (1995).
   PubMedGoogle Scholar
• Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep14(6), 540–545 (1991).
   PubMed Web of Science ®Google Scholar
• Littner MR, Kushida C, Wise M et al. Standards of Practice Committee of the American Academy of Sleep Medicine. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep28(1), 113–121 (2005).
   PubMed Web of Science ®Google Scholar
• Thorpy MJ. Cataplexy associated with narcolepsy: epidemiology, pathophysiology and management. CNS Drugs20, 43–50 (2006).
   PubMedGoogle Scholar
• Overeem S, Reijntjes R, Huyser W, Lammers GJ, van Dijk JG. Corticospinal excitability during laughter: implications for cataplexy and the comparison with REM sleep atonia. J. Sleep Res.13, 257–264 (2004).
   PubMedGoogle Scholar
• Houghton WC, Scammell TE, Thorpy M. Pharmacotherapy for cataplexy. Sleep Med. Rev.8, 355–366 (2004).
   PubMed Web of Science ®Google Scholar
• Overeem S, Mignot E, van Dijk JG, Lammers GJ. Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives. J. Clin. Neurophysiol.18, 78–105 (2001).
   PubMed Web of Science ®Google Scholar
• Hishikawa Y, Shimizu T. Physiology of REM sleep, cataplexy, and sleep paralysis. Adv. Neurol.67, 245–271 (1995).
   PubMedGoogle Scholar
• Dahlitz M, Parkes JD. Sleep paralysis. Lancet341, 406–407 (1993).
   PubMed Web of Science ®Google Scholar
• Montplaisir J, Billiard M, Takahashi S, Bell IR, Guilleminault C, Dement WC. Twenty-four-hour recording in REM-narcoleptics with special reference to nocturnal sleep disruption. Biol. Psychiatry13(1), 73–89 (1978).
   PubMed Web of Science ®Google Scholar
• Harsh J, Peszka J, Hartwig G, Mitler M. Night-time sleep and daytime sleepiness in narcolepsy. J. Sleep Res.9, 309–316 (2000).
   PubMed Web of Science ®Google Scholar
• Schenck CH, Mahowald MW. Motor dyscontrol in narcolepsy: rapid-eye-movement (REM) sleep without atonia and REM sleep behavior disorder. Ann. Neurol.32(1), 3–10 (1992).
   PubMed Web of Science ®Google Scholar
• Nightingale S, Orgill JC, Ebrahim IO, de Lacy SF, Agrawal S, Williams AJ. The association between narcolepsy and REM behavior disorder (RBD). Sleep Med.6, 253–258 (2005).
   PubMedGoogle Scholar
• Chokroverty S. Sleep apnea in narcolepsy. Sleep9(1), 250–253 (1986).
   PubMed Web of Science ®Google Scholar
• Schuld A, Hebebrand J, Geller F, Pollmacher T. Increased body-mass index in patients with narcolepsy. Lancet355(9211), 1274–1275 (2000).
   PubMed Web of Science ®Google Scholar
• Kotagal S, Krahn LE, Slocumb N. A putative link between childhood narcolepsy and obesity. Sleep Med.5, 147–150 (2004).
   PubMedGoogle Scholar
• Lammers GJ, Pijl H, Iestra J, Langius JAE, Buunk G, Meinders AE. Spontaneous food choice in narcolepsy. Sleep19(1), 75–76 (1996).
   PubMed Web of Science ®Google Scholar
• Honda Y, Doi Y, Ninomiya R, Ninomiya C. Increased frequency of non-insulin-dependent diabetes mellitus among narcoleptic patients. Sleep9(1), 254–259 (1986).
   PubMed Web of Science ®Google Scholar
• Vandeputte M, de Weerd A. Sleep disorders and depressive feelings: a global survey with the Beck depression scale. Sleep Med.4, 343–345 (2003).
   PubMed Web of Science ®Google Scholar
• de Lecea L, Kildu TS, Peyron C et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl Acad. Sci. USA95, 322–327 (1998).
   PubMed Web of Science ®Google Scholar
• Sakurai T, Amemiya A, Ishii M et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell92, 573–585 (1998).
   PubMed Web of Science ®Google Scholar
• Lin L, Faraco J, Li R, Kadotani H et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell98(3), 365–376 (1999).
   PubMed Web of Science ®Google Scholar
• Chemelli RM, Willie JT, Sinton CM et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell98(4), 437–451 (1999).
   PubMed Web of Science ®Google Scholar
• Sakurai T. Roles of orexin/hypocretin in regulation of sleep/wakefulness and energy homeostasis. Sleep Med. Rev.9, 231–241 (2005).
   PubMed Web of Science ®Google Scholar
• Peyron C, Tighe DK, van den Pol AN et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci.18, 9996–10015 (1998).
   PubMed Web of Science ®Google Scholar
• Hishikawa Y, Shimizu T. Physiology of REM sleep, cataplexy, and sleep paralysis. Adv. Neurol.67, 245–271 (1995).
   PubMedGoogle Scholar
• Siegel JM. REM Sleep. In: Principles and Practice of Sleep Medicine. Kryger MH, Roth T, Dement CD (Eds). Elsevier Saunders Editor, Philadelphia, PA, USA 120–135 (2005).
   Google Scholar
• Wu MF, John J, Boehmer LN, Yao D, Nguyen GB, Siegel JM. Activity of dorsal raphe cells across the sleep–waking cycle and during cataplexy in narcoleptic dogs. J. Physiol.554(Pt 1), 202–215 (2004).
   PubMed Web of Science ®Google Scholar
• Simón-Arceo K, Ramírez-Salado I, Calvo JM. Long-lasting enhancement of rapid eye movement sleep and pontogeniculooccipital waves by vasoactive intestinal peptide microinjection into the amygdala temporal lobe. Sleep26(3), 259–264 (2003).
   PubMedGoogle Scholar
• McGinty D, Szymusiak R. Sleep-promoting mechanisms in mammals. In: Principles and Practice of Sleep Medicine. Kryger MH, Roth T, Dement CD (Eds). Elsevier Saunders, Philadelphia, PA, USA 169–184 (2005).
   Google Scholar
• Lu J, Sherman D, Devor M, Saper CB. A putative flip-flop switch for control of REM sleep. Nature441(7093), 589–594 (2006).
   PubMed Web of Science ®Google Scholar
• Ferrillo F, Donadio S, De Carli F, Garbarino S, Nobili L. A model-based approach to homeostatic and ultradian aspects of nocturnal sleep structure in narcolepsy. Sleep. 30(2), 157–165 (2007).
   PubMedGoogle Scholar
• Nishino S, Kanbayashi T. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Med. Rev.9, 269–310 (2005).
   PubMed Web of Science ®Google Scholar
• Billiard M, Bassetti C, Dauvilliers Y et al. EFNS guidelines on management of narcolepsy. Eur. J. Neurol.13, 1035–1048 (2006).
   PubMed Web of Science ®Google Scholar
• Mignot E. An update on the pharmacotherapy of excessive daytime sleepiness and cataplexy. Guest Editorial. Sleep Med. Rev.8, 333–338 (2004).
   PubMedGoogle Scholar
• Banerjee D, Vitiello MV, Grunstein RR. Pharmacotherapy for excessive daytime sleepiness. Sleep Med. Rev.8, 339–354 (2004).
   PubMedGoogle Scholar
• Gallopin T, Luppi PH, Rambert FA, Frydman A, Fort P. Effect of the wake-promoting agent modafinil on sleep-promoting neurons from the ventrolateral preoptic nucleus: an in vitro pharmacologic study. Sleep27, 19–25 (2004).
   PubMed Web of Science ®Google Scholar
• Scammell TE, Estabrooke IV, McCarthy MT, Chemelli RM, Yanagisawa M, Miller MS. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J. Neurosci.20(22), 8620–8628 (2000).
   PubMed Web of Science ®Google Scholar
• Ishizuka T, Sakamoto Y, Sakurai T, Yamatodani A. Modafinil increases histamine release in the anterior hypothalamus of rats. Neurosci. Lett.339, 143–146 (2003).
   PubMed Web of Science ®Google Scholar
• Ferraro L, Fuxe K, Tanganelli S, Fernandez M, Lambert FA, Antonelli T. Amplification of cortical serotonin release: a further neurochemical action of the vigilance promoting drug modafinil. Neuropharmacology39, 1974–1983 (2000).
   PubMed Web of Science ®Google Scholar
• Robertson P Jr, Hellriegel ET. Clinical pharmacokinetic profile of modafinil. Clin. Pharmacokinet.42(2), 123–137 (2003).
   PubMed Web of Science ®Google Scholar
• Billiard M, Besset A, Montplaisir J et al. Modafinil: a double-blind multicenter study. Sleep17 (Suppl.), 107–112 (1994).
   PubMed Web of Science ®Google Scholar
• Broughton RJ, Fleming JAE, George CFP et al. Randomized, double-blind, placebo-controlled crossover of modafinil in the treatment of excessive daytime sleepiness in narcolepsy. Neurology49, 444–451 (1997).
   PubMed Web of Science ®Google Scholar
• US Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Ann. Neurol.43, 88–97 (1998).
   PubMed Web of Science ®Google Scholar
• US Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy. Neurology54, 1166–1175 (2000).
   PubMed Web of Science ®Google Scholar
• Schwartz JR, Feldman NT, Bogan RK, Nelson MT, Hughes RJ. Dosing regimen of modafinil for improving daytime wakefulness in patients with narcolepsy. Clin. Neuropharmacol.26, 252–257 (2003).
   PubMed Web of Science ®Google Scholar
• Moldofsky H, Broughton RJ, Hill JD. A randomized trial of the long-term, continued efficacy and safety of modafinil in narcolepsy. Sleep Med.1, 109–116 (2000).
   PubMed Web of Science ®Google Scholar
• Mitler MM, Hirsh J, Hirshkowitz M, Guilleminault C; for the US Modafinil in Narcolepsy Multicenter Study Group. Long-term efficacy and safety of modafinil (PROVIGIL®) for the treatment of excessive daytime sleepiness associated with narcolepsy. Sleep Med.1, 231–243 (2000).
   PubMed Web of Science ®Google Scholar
• Emsellem HA, Waskington DC and the US Modafinil Study Group. Efficacy and safety profiles of modafinil maintained during long-term (40 and 88 weeks) treatment of excessive daytime sleepiness associated with narcolepsy. Neurology54(7 Suppl. 3), A29–A30 (2000).
   Google Scholar
• Hirshkowitz M, Schwartz J, Corser B. Long-term (136 weeks) safety and efficacy of modafinil for the treatment of excessive daytime sleepiness associated with narcolepsy. Sleep24(Suppl.), A329 (2001).
   Google Scholar
• Ivanenko A, Tauman R, Gozal D. Modafinil in the treatment of excessive daytime sleepiness in children. Sleep Med.4(6), 579–582 (2003).
   PubMed Web of Science ®Google Scholar
• Mitler MM, Aldrich MS, Koob GF, Zarcone VP. Narcolepsy and its treatment with stimulants. Sleep17(4), 352–371 (1994).
   PubMed Web of Science ®Google Scholar
• Aldrich MS. Narcolepsy. N. Engl. J. Med.323(6), 389–394 (1990).
   PubMed Web of Science ®Google Scholar
• Robinson DM, Keuting GM. Sodium oxybate: a review of its use in the management of narcolepsy. CNS Drugs21(4), 337–354 (2007).
   PubMed Web of Science ®Google Scholar
• US Xyrem Multicenter Study Group. A randomized, double-blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep25, 42–49 (2002).
   PubMed Web of Science ®Google Scholar
• US Xyrem Multicenter Study Group. A 12-month, open-label multi-center extension trial of orally administered sodium oxybate for the treatment of narcolepsy. Sleep26, 31–35 (2003).
   PubMed Web of Science ®Google Scholar
• Mamelak M, Black J, Montplasir J. A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy. Sleep27, 1327–1334 (2004).
   PubMed Web of Science ®Google Scholar
• The Xyrem International Study Group. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy. J. Clin. Sleep Med.1, 391–397 (2005).
   PubMed Web of Science ®Google Scholar
• Black J, Houghton WC. Sodium oxybate improves excessive daytime sleepiness in narcolepsy. Sleep29, 939–946 (2006).
   PubMed Web of Science ®Google Scholar
• Stahl S. Essential Psychopharmacology (1st Edition). Cambridge University Press, Cambridge, UK (2005).
   Google Scholar
• Hublin C, Partinen M, Heinonen E, Puuka P, Salmi T. Selegiline in the treatment of narcolepsy. Neurology44, 2095–2101 (1994).
   PubMed Web of Science ®Google Scholar
• Mayer G, Meier-Ewert K. Selegiline hydrochloride treatment in narcolepsy. A double-blind, placebo-controlled study. Clin. Neuropharmacol.18, 306–319 (1995).
   PubMed Web of Science ®Google Scholar
• Wise MS, Arand DL, Auger RR, Brooks SN, Watson NF; American Academy of Sleep Medicine. Treatment of narcolepsy and other hypersomnias of central origin. Sleep30(12), 1712–1727 (2007).
   PubMed Web of Science ®Google Scholar
• Mullington J, Broughton R. Scheduled naps in the management of daytime sleepiness in narcolepsy–cataplexy. Sleep16, 444–456 (1993).
   PubMed Web of Science ®Google Scholar
• Potter W, Manji HK, Rudorfer MV. Triciclici e tetraciclici. In: The American Psychiatric Press Textbook of Psychopharmacology (2nd Edition). Schatzberg AF, Nemeroff CB (Eds). Italian Edition, Centro Scientifico Editore, Italy 199–218 (2001).
   Google Scholar
• Tollefson GD, Rosenbaum JF. Inibitori selettivi della ricaptazione della serotonina. In: The American Psychiatric Press Textbook of Psychopharmacology (Second Edition). Schatzberg AF, Nemeroff CB (Eds). Italian Edition, Centro Scientifico Editore, Italy 219–237 (2001).
   Google Scholar
• Billiard M. Narcolepsy: current treatment options and future approaches. Neuropsychiatr. Dis. Treat.4(3), 557–566 (2008).
   PubMedGoogle Scholar
• Hecht M, Lin L, Kushida CA et al. Report of a case of immunosuppression with prednisone in an 8-year-old boy with an acute onset of hypocretin-deficiency narcolepsy. Sleep26(7), 809–810 (2003).
   PubMed Web of Science ®Google Scholar
• Chen W, Black J, Call P, Mignot E. Late-onset narcolepsy presenting as rapidly progressing muscle weakness: response to plasmapheresis. Ann. Neurol.58(3), 489–490 (2005).
   PubMed Web of Science ®Google Scholar
• Lecendreux M, Maret S, Bassetti C, Mouren MC, Tafti M. Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy. J. Sleep Res.12(4), 347–348 (2003).
   PubMed Web of Science ®Google Scholar
• Dauvilliers Y, Carlander B, Touchon J, Tafti M. Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset. Ann. Neurol.56, 905–908 (2004).
   PubMed Web of Science ®Google Scholar
• Zuberi SM, Mignot E, Ling L, Mcarthur I. Variable response to intravenous immunoglobulin therapy in childhood narcolepsy. J. Sleep Res.13(Suppl. 1), 828 (2004).
   Google Scholar
• Plazzi G, Poli F, Franceschini C et al. Intravenous high-dose immunoglobulin treatment in recent onset childhood narcolepsy with cataplexy. J. Neurol.255(10), 1549–1554 (2008).
   PubMed Web of Science ®Google Scholar
• Valko PO, Khatami R, Baumann CR, Bassetti CL. No persistent effect of intravenous immunoglobulins in patients with narcolepsy with cataplexy. J. Neurol.255(12), 1900–1903 (2008).
   PubMed Web of Science ®Google Scholar
• Nishino S, Okuro M. Armodafinil for excessive daytime sleepiness. Drugs Today (Barc.)44(6), 395–414 (2008).
   PubMed Web of Science ®Google Scholar
• Lankford DA. Armodafinil: a new treatment for excessive sleepiness. Expert Opin. Investig. Drugs17(4), 565–573 (2008).
   PubMed Web of Science ®Google Scholar